当前位置:首页 - 行情中心 - 开尔新材(300234) - 财务分析 - 利润表

开尔新材

(300234)

  

流通市值:13.21亿  总市值:19.32亿
流通股本:3.44亿   总股本:5.03亿

利润表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、营业总收入614,983,103.67323,575,051.47220,652,746.0674,841,018.35
营业收入614,983,103.67323,575,051.47220,652,746.0674,841,018.35
二、营业总成本537,198,696.31304,202,769.13204,944,054.3273,958,186.14
营业成本426,705,292.92225,419,699.67149,416,855.2747,846,459.95
税金及附加5,504,252.613,778,989.392,603,960.141,262,175.45
销售费用22,093,749.912,709,298.048,117,779.593,576,008.55
管理费用60,373,491.9746,113,444.1232,625,747.2214,701,816.22
研发费用26,403,579.3318,550,802.6412,613,017.956,113,189.04
财务费用-3,881,670.42-2,369,464.73-433,305.85458,536.93
其中:利息费用1,789,842.121,687,549.541,279,236.11493,294.59
其中:利息收入6,454,248.343,912,057.911,064,409.36680,085.45
加:公允价值变动收益280,071.751,325,873.54935,579.87624,144.32
加:投资收益1,693,584.17531,410.16191,546.3-52,278.57
资产处置收益229,297.05278,795.15302,000.45258,297.53
资产减值损失(新)-9,585,749.71-3,371,469.3316,549.69285,165.28
信用减值损失(新)-2,364,272.4817,514,863.4910,125,335.669,769,895.3
其他收益10,310,821.985,958,020.053,579,370.281,067,069.03
营业利润平衡项目0000
四、营业利润78,348,160.1241,609,775.4331,159,073.9912,835,125.1
加:营业外收入1,203,198.16890,134.13817,228.2110,068.73
减:营业外支出2,033,415.741,698,669.49258,123.18128,079.44
利润总额平衡项目0000
五、利润总额77,517,942.5440,801,240.0731,718,179.0212,717,114.39
减:所得税费用4,170,660.484,586,944.483,441,406.581,408,874.09
六、净利润73,347,282.0636,214,295.5928,276,772.4411,308,240.3
持续经营净利润73,347,282.0636,214,295.5928,276,772.4411,308,240.3
归属于母公司股东的净利润74,385,431.636,308,930.2927,876,530.8510,712,282.14
少数股东损益-1,038,149.54-94,634.7400,241.59595,958.16
(一)基本每股收益0.150.070.060.02
(二)稀释每股收益0.150.070.060.02
八、其他综合收益-454,093.84-854,187.33-1,006,720.79626,263.8
归属于母公司股东的其他综合收益-317,865.69-597,931.13-704,704.55438,384.66
九、综合收益总额72,893,188.2235,360,108.2627,270,051.6511,934,504.1
归属于母公司股东的综合收益总额74,067,565.9135,710,999.1627,171,826.311,150,666.8
归属于少数股东的综合收益总额-1,174,377.69-350,890.998,225.35783,837.3
公告日期2024-04-032023-10-282023-08-122023-04-26
审计意见(境内)标准无保留意见
TOP↑